Amgen (NASDAQ:AMGN) Raised to Strong-Buy at StockNews.com
Amgen (NASDAQ:AMGN – Get Free Report) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday. AMGN has been the subject of several other research reports. Piper Sandler lifted their target price on shares of Amgen from $310.00 to $329.00 and gave the stock […]
